January 28, 2018 / 10:57 PM / 3 months ago

BRIEF-Prescient Therapeutics Updates On PTX-200 Clinical Trials

Jan 29 (Reuters) - Prescient Therapeutics Ltd:

* ALL PTX-200 TRIALS NOW OFF CLINICAL HOLD & EITHER CURRENTLY RECRUITING OR IN PROCESS OF GETTING APPROVALS TO START RECRUITMENT​

* ‍FINAL RESULTS FROM PHASE 1B TRIAL OF PTX-200 EXPECTED Q1 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below